209 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Pseudodeflectusin, a novel isochroman derivative from Aspergillus pseudodeflectus a parasite of the sea weed, Sargassum fusiform, as a selective human cancer cytotoxin.
Tokyo University of Science
Design, synthesis and evaluation of novel indandione derivatives as multifunctional agents with cholinesterase inhibition, anti-ß-amyloid aggregation, antioxidant and neuroprotection properties against Alzheimer's disease.
University of Delhi
Structure-Activity Relationship Studies of Isomeric 2,4-Diaminoquinazolines onß-Amyloid Aggregation Kinetics.
University of Waterloo
Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as multi-targeted compounds against Alzheimer's disease.
Guangzhou Medical University
Part 1: Notch-sparing¿-secretase inhibitors: The identification of novel naphthyl and benzofuranyl amide analogs.
Harvard Medical School
Amyloid cascade in Alzheimer's disease: Recent advances in medicinal chemistry.
University of Waterloo
Synthesis of pyrimido[4,5-c]azepine- and pyrimido[4,5-c]oxepine-based¿-secretase modulators.
Bristol-Myers Squibb
Design and optimization of tricyclic gamma-secretase modulators.
Bristol-Myers Squibb Research and Development
Design and discovery of Novel Thiazole acetamide derivatives as anticholinesterase agent for possible role in the management of Alzheimer's.
Linyi People'S Hospital
Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography.
China Pharmaceutical University
Structural insights into mechanisms for inhibiting amyloidß42 aggregation by non-catechol-type flavonoids.
Kyoto University
Diversification of edaravone via palladium-catalyzed hydrazine cross-coupling: Applications against protein misfolding and oligomerization of beta-amyloid.
Dalhousie University
Discovery of a Novel, Potent Spirocyclic Series of¿-Secretase Inhibitors.
Merck Research Laboratories
Highly Efficient Synthesis of 1,3-Dihydroxy-2-carboxycarbazole and Its Neuroprotective Effects.
Virginia Commonwealth University
Potent benzoazepinone¿-secretase modulators with improved bioavailability.
Merck Research Laboratories
Design, Synthesis, and Characterization of 3-(Benzylidene)indolin-2-one Derivatives as Ligands fora-Synuclein Fibrils.
Washington University
Discovery of indole-derived pyridopyrazine-1,6-dione¿-secretase modulators that target presenilin.
Pfizer
Design of Pyridopyrazine-1,6-dione¿-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability.
Pfizer
3,5-Diarylpyrazole Derivatives Obtained by Ammonolysis of the Total Flavonoids from Chrysanthemum indicum Extract Show Potential for the Treatment of Alzheimer's Disease.
Sun Yat-Sen University
SAR-studies of¿-secretase modulators with PPAR¿-agonistic and 5-lipoxygenase-inhibitory activity for Alzheimer's disease.
Goethe-University Frankfurt
Naturally occurring polyphenolic inhibitors of amyloid beta aggregation.
Csiro Manufacturing Flagship (Biomedical)
Imidazo[2,1]thiazol-3-one Derivatives Useful as Diagnostic Agents for Alzheimer's Disease.
Temple University
Oxidative stress in Alzheimer's disease: are we connecting the dots?
University of Bologna
Polyfluorinated bis-styrylbenzenes as amyloid-ß plaque binding ligands.
Leiden University
Discovery of SCH 900229, a Potent Presenilin 1 Selective ¿-Secretase Inhibitor for the Treatment of Alzheimer's Disease.
TBA
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 4. Further investigation on the inner spacer.
University of Bologna
Aminostyrylbenzofuran derivatives as potent inhibitors for Abeta fibril formation.
Institute of Science and Technology
Stereochemical analysis of (hydroxyethyl)urea peptidomimetic inhibitors of gamma-secretase.
Harvard Medical School
Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging.
Sungkyunkwan University School of Medicine
F-18 stilbenes as PET imaging agents for detecting beta-amyloid plaques in the brain.
University of Pennsylvania
Secretase targets for Alzheimer's disease: identification and therapeutic potential.
Harvard Medical School
Probing pockets S2-S4' of the gamma-secretase active site with (hydroxyethyl)urea peptidomimetics.
Harvard Medical School
Diphenylpropynone derivatives as probes for imagingß-amyloid plaques in Alzheimer's brains.
Kyoto University
Novel pyrrolyl 2-aminopyridines as potent and selective human beta-secretase (BACE1) inhibitors.
Wyeth
Discovery and initial optimization of 5,5'-disubstituted aminohydantoins as potent beta-secretase (BACE1) inhibitors.
Wyeth Research
(3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone: a potent, selective, orally active dipeptidyl peptidase IV inhibitor.
Pfizer
Small conformationally restricted piperidine N-arylsulfonamides as orally active gamma-secretase inhibitors.
Schering-Plough Research Institute
Design, synthesis, and evaluation of tetrahydroquinoline and pyrrolidine sulfonamide carbamates as gamma-secretase inhibitors.
Pharmacopeia Drug Discovery
Small molecule-based fluorescent probes for the detection of ?-Synuclein aggregation states.
Csir-Indian Institute of Chemical Technology (CSIR-IICT)
Anti-A?42 Aggregative Polyketides from the Antarctic Psychrophilic Fungus
Ocean University of China
DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspective.
Jamia Hamdard
A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease.
Tehran University of Medical Sciences
Discovery of novel hybrids containing clioquinol-1-benzyl-1,2,3,6-tetrahydropyridine as multi-target-directed ligands (MTDLs) against Alzheimer's disease.
China Pharmaceutical University
Geminal Diheteroatomic Motifs: Some Applications of Acetals, Ketals, and Their Sulfur and Nitrogen Homologues in Medicinal Chemistry and Drug Design.
Bristol Myers Squibb Research and Early Development
Evolution in non-peptide ?-helix mimetics on the road to effective protein-protein interaction modulators.
Instituto De Qu£Mica M£Dica
Bioactive Aurones, Indanones, and Other Hemiindigoid Scaffolds: Medicinal Chemistry and Photopharmacology Perspectives.
Universite Grenoble Alpes
Imidazo[1,2-b]pyridazine as privileged scaffold in medicinal chemistry: An extensive review.
Universite de Tours
Synthesis and properties of the kojic acid dimer and its potential for the treatment of Alzheimer's disease.
Fujian Medical University
Rational Multitargeted Drug Design Strategy from the Perspective of a Medicinal Chemist.
Shandong University
Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions.
Sichuan University
Synthesis of biotinylated photoaffinity probes based on arylsulfonamide gamma-secretase inhibitors.
University of Tokyo
3-Substituted gem-cyclohexane sulfone based gamma-secretase inhibitors for Alzheimer's disease: conformational analysis and biological activity.
Merck Sharp and Dohme Research Laboratories
Novel gamma-secretase inhibitors discovered by library screening of in-house synthetic natural product intermediates.
University of Tokyo
Synthesis of biphenyltrienes as probes for beta-amyloid plaques.
University of Pennsylvania
Novel benzofuran derivatives for PET imaging of beta-amyloid plaques in Alzheimer's disease brains.
Nagasaki University
3,4-Fused cyclohexyl sulfones as gamma-secretase inhibitors.
Neuroscience Research Centre
Synthesis and evaluation of two 18F-labeled imidazo[1,2-a]pyridine analogues as potential agents for imaging beta-amyloid in Alzheimer's disease.
Emory University
Synthesis, biological evaluation, and molecular modeling simulations of new heterocyclic hybrids as multi-targeted anti-Alzheimer's agents.
Mansoura University
Synthesis and evaluation of succinoyl-caprolactam gamma-secretase inhibitors.
Bristol-Myers Squibb Pharmaceutical Research Institute
Amyloid-? and tau aggregation dual-inhibitors: A synthetic and structure-activity relationship focused review.
University of Aveiro
Design, synthesis, and structure-activity relationship of novel thiophene derivatives for beta-amyloid plaque imaging.
University of Pennsylvania
Radioiodinated flavones for in vivo imaging of beta-amyloid plaques in the brain.
Nagasaki University
Near-Infrared Fluorescent Probes as Imaging and Theranostic Modalities for Amyloid-Beta and Tau Aggregates in Alzheimer's Disease.
Indian Institute of Technology (Bhu)
Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretion.
Chiesi Farmaceutici
Cyclic sulfamide gamma-secretase inhibitors.
Merck Sharp and Dohme Research Laboratories
Inhibition of ?-Amyloid Aggregation in Alzheimer's Disease: The Key Role of (Pro)electrophilic Warheads.
Alma Mater Studiorum - University of Bologna
Chemical analysis of amyloid ? aggregation inhibitors derived from Geranium thunbergii.
Muroran Institute of Technology
Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease.
Central University of Punjab
Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy.
"G. D'Annunzio" University of Chieti-Pescara
Small molecules targeting ?-secretase and their potential biological applications.
Shenyang Pharmaceutical University
Therapeutic potential of quinazoline derivatives for Alzheimer's disease: A comprehensive review.
University of Louisiana At Lafayette
New A?(1-42) ligands from anti-amyloid antibodies: Design, synthesis, and structural interaction.
University of Salerno
Structural modification aimed for improving solubility of lead compounds in early phase drug discovery.
Indian Institute of Technology (B.H.U.)
Aryl sulfones: a new class of gamma-secretase inhibitors.
Merck Sharp & Dohme Research Laboratories
Molecular-modeling based design, synthesis, and activity of substituted piperidines as gamma-secretase inhibitors.
Wyeth Research
Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress.
Guizhou Medical University
A novel series of potent gamma-secretase inhibitors based on a benzobicyclo[4.2.1]nonane core.
Merck Sharp & Dohme Research Laboratories
Synthesis of the Potent, Selective, and Efficacious ?-Secretase (BACE1) Inhibitor NB-360.
TBA
Discovery of Umibecestat (CNP520): A Potent, Selective, and Efficacious ?-Secretase (BACE1) Inhibitor for the Prevention of Alzheimer's Disease.
Novartis Pharma
A Brain-Penetrant and Bioavailable Pyrazolopiperazine BACE1 Inhibitor Elicits Sustained Reduction of Amyloid ? In Vivo.
Janssen Research & Development
Discovery of a Subnanomolar helical D-tridecapeptide inhibitor of gamma-secretase.
Harvard Medical School
Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT
Jagiellonian University Medical College
Inhibition of BACE1 and Amyloid-? Aggregation by Meroterpenoids from the Mushroom
Meiji Pharmaceutical University
Parallel synthesis of DAPT derivatives and their gamma-secretase-inhibitory activity.
University of Tokyo
Novel hydroxybenzylamine-deoxyvasicinone hybrids as anticholinesterase therapeutics for Alzheimer's disease.
University of Arkansas For Medical Sciences
Design of Transmembrane Mimetic Structural Probes to Trap Different Stages of ?-Secretase-Substrate Interaction.
University of Kansas
Design, synthesis, and biological evaluation of furosemide analogs as therapeutics for the proteopathy and immunopathy of Alzheimer's disease.
University Health Network
Design, synthesis and in-vitro evaluation of fluorinated triazoles as multi-target directed ligands for Alzheimer disease.
National Institute of Pharmaceutical Education and Research (NIPER)
High affinity, bioavailable 3-amino-1,4-benzodiazepine-based gamma-secretase inhibitors.
Merck Sharp & Dohme Research Laboratories
Design, synthesis and evaluation of novel dimethylamino chalcone-O-alkylamines derivatives as potential multifunctional agents against Alzheimer's disease.
Nanyang Normal University
Design, synthesis and biological evaluation of 2-styryl-5-hydroxy-4-pyrone derivatives and analogues as multiple functional agents with the potential for the treatment of Alzheimer's disease.
Zhejiang University
Ferulic acid amide derivatives with varying inhibition of amyloid-? oligomerization and fibrillization.
University of Toronto
Design, synthesis and biological evaluation of novel deoxyvasicinone-indole as multi-target agents for Alzheimer's disease.
Kakatiya University
Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.
University of Pittsburgh
Inhibitors of Abeta production: solid-phase synthesis and SAR of alpha-hydroxycarbonyl derivatives.
Bristol-Myers Squibb Pharmaceutical Research Institute
Structure-activity relationship of imidazo[1,2-a]pyridines as ligands for detecting beta-amyloid plaques in the brain.
University of Pennsylvania
Synthesis and gamma-secretase activity of APP substrate-based hydroxyethylene dipeptide isosteres.
Merck Sharp & Dohme Research Laboratories
Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities.
Zhejiang University
Novel deoxyvasicinone and tetrahydro-beta-carboline hybrids as inhibitors of acetylcholinesterase and amyloid beta aggregation.
Xinyang Normal University
Toward the discovery and development of effective modulators of ?-synuclein amyloid aggregation.
Universit£
Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer's disease.
Taipei Medical University
Discovery of Orally Active Hydroxyethylamine Based SPPL2a Inhibitors.
Novartis Institutes For Biomedical Research
Inhibiting A? toxicity in Alzheimer's disease by a pyridine amine derivative.
Nanjing University
Isomerization of (Z,Z) to (E,E)1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene in strong base: probes for amyloid plaques in the brain.
University of Pennsylvania
Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates.
University of Pennsylvania
Discovery of N-ethylpyridine-2-carboxamide derivatives as a novel scaffold for orally active ?-secretase modulators.
Astellas Pharma
Isolation of three new meroterpenoids and seven known compounds from Albatrellus yasudae and their A?-aggregation inhibitory activity.
Meiji Pharmaceutical University
Fenchylamine sulfonamide inhibitors of amyloid beta peptide production by the gamma-secretase proteolytic pathway: potential small-molecule therapeutic agents for the treatment of Alzheimer's disease.
Amgen
Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
Indian Institute of Technology (Banaras Hindu University)
Ellagic acid a multi-target bioactive compound for drug discovery in CNS? A narrative review.
University of Genoa
A multifunctional therapeutic approach: Synthesis, biological evaluation, crystal structure and molecular docking of diversified 1H-pyrazolo[3,4-b]pyridine derivatives against Alzheimer's disease.
Jamia Millia Islamia (Central University)
Naphthalene-triazolopyrimidine hybrid compounds as potential multifunctional anti-Alzheimer's agents.
Jamia Millia Islamia (Central University)
Naturally occurring biflavonoids with amyloid ? aggregation inhibitory activity for development of anti-Alzheimer agents.
Meiji Pharmaceutical University
Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease.
Jining Medical University
Discovery of novel 2,5-dihydroxyterephthalamide derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Sichuan University
Triazole derivatives as inhibitors of Alzheimer's disease: Current developments and structure-activity relationships.
Wuhan Institute of Technology
Development of novel theranostic agents for in vivo amyloid imaging and protective effects on human neuroblastoma cells.
Guangdong University of Technology
Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review.
Wuhan University of Technology
Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018).
Csir-Central Drug Research Institute
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms.
China Pharmaceutical University
Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs.
University of Barcelona
Discovery and characterization of novel indole and 7-azaindole derivatives as inhibitors of ?-amyloid-42 aggregation for the treatment of Alzheimer's disease.
Ac Immune
Synthesis and biological evaluation of deferiprone-resveratrol hybrids as antioxidants, A?
Zhejiang Chinese Medical University
Synthesis and structure-activity relationship of 2,6-disubstituted pyridine derivatives as inhibitors of ?-amyloid-42 aggregation.
Ac Immune
Preliminary evaluation of fluoro-pegylated benzyloxybenzenes for quantification of ?-amyloid plaques by positron emission tomography.
Beijing Normal University
Spiroindole Alkaloids and Spiroditerpenoids from Aspergillus duricaulis and Their Potential Neuroprotective Effects.
Korea University
?-sheet interfering molecules acting against ?-amyloid aggregation and fibrillogenesis.
Sapienza University of Rome
Radioiodinated benzyloxybenzene derivatives: a class of flexible ligands target to ?-amyloid plaques in Alzheimer's brains.
Beijing Normal University
Homoisoflavonoids as potential imaging agents for ?-amyloid plaques in Alzheimer's disease.
Hefei University of Technology
Quinones bearing non-steroidal anti-inflammatory fragments as multitarget ligands for Alzheimer's disease.
Alma Mater Studiorum University of Bologna
Syntheses and evaluation of novel isoliquiritigenin derivatives as potential dual inhibitors for amyloid-beta aggregation and 5-lipoxygenase.
Sun Yat-Sen University
Structure-Activity Relationships and in Vivo Evaluation of Quinoxaline Derivatives for PET Imaging of ?-Amyloid Plaques.
Kyoto University
Synthesis and biological evaluation of 18F-labled 2-phenylindole derivatives as PET imaging probes for ?-amyloid plaques.
Beijing Normal University
Therapeutic and pharmacokinetic characterizations of an anti-amyloidogenic bis-styrylbenzene derivative for Alzheimer's disease treatment.
Korea Institute of Science and Technology
Design, synthesis and biological activity of multifunctional ?,?-unsaturated carbonyl scaffolds for Alzheimer's disease.
University of Massachusetts Boston
Synthesis of tetrahydroxybiphenyls and tetrahydroxyterphenyls and their evaluation as amyloid-? aggregation inhibitors.
Winthrop University
Synthesis and biological evaluation of radioiodinated quinacrine-based derivatives for SPECT imaging of A? plaques.
Nagasaki University
Synthesis and Evaluation of 5-Fluoro-2-aryloxazolo[5,4-b]pyridines as ?-Amyloid PET Ligands and Identification of MK-3328.
Merck Research Laboratories
Discovery of novel inhibitors of amyloid ?-peptide 1-42 aggregation.
Universidad De Zaragoza
Synthesis and evaluation of ¹?F-labeled styryltriazole and resveratrol derivatives for ?-amyloid plaque imaging.
Sungkyunkwan University School of Medicine
Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid ?-protein.
University of Tsukuba
Design of ?-amyloid aggregation inhibitors from a predicted structural motif.
Stanford University
The ?-Amyloid Hypothesis in Alzheimer's Disease: Seeing Is Believing.
University of Pennsylvania
Small molecules that protect against ?-amyloid-induced cytotoxicity by inhibiting aggregation of ?-amyloid.
Korea Institute of Science and Technology
Synthesis and evaluation of pyridylbenzofuran, pyridylbenzothiazole and pyridylbenzoxazole derivatives as ¹?F-PET imaging agents for ?-amyloid plaques.
Astrazeneca
Multidentate (18)F-polypegylated styrylpyridines as imaging agents for A? plaques in cerebral amyloid angiopathy (CAA).
University of Pennsylvania
A Novel (18)F-Labeled Imidazo[2,1-b]benzothiazole (IBT) for High-Contrast PET Imaging of ?-Amyloid Plaques.
Technische Universit£T M£Nchen
Synthesis and in vitro evaluation of fluorinated styryl benzazoles as amyloid-probes.
Instituto Tecnol£Gico E Nuclear
Aromatic radiofluorination and biological evaluation of 2-aryl-6-[18F]fluorobenzothiazoles as a potential positron emission tomography imaging probe for ?-amyloid plaques.
Seoul National University Bundang Hospital
Synthesis and evaluation of 11C-labeled imidazo[2,1-b]benzothiazoles (IBTs) as PET tracers for imaging ?-amyloid plaques in Alzheimer's disease.
Technische Universit£T M£Nchen
Synthesis and evaluation of 2-pyridylbenzothiazole, 2-pyridylbenzoxazole and 2-pyridylbenzofuran derivatives as 11C-PET imaging agents for beta-amyloid plaques.
Astrazeneca
Novel anilinophthalimide derivatives as potential probes for beta-amyloid plaque in the brain.
Beijing Normal University
18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective.
University of Pennsylvania
Synthesis and evaluation of three 18F-labeled aminophenylbenzothiazoles as amyloid imaging agents.
Katholieke Universiteit Leuven
11C-labelled PIB analogues as potential tracer agents for in vivo imaging of amyloid beta in Alzheimer's disease.
K.U. Leuven
Synthesis of 18F-labelled 2-(4'-fluorophenyl)-1,3-benzothiazole and evaluation as amyloid imaging agent in comparison with [11C]PIB.
K.U.Leuven
Synthesis and evaluation of 18F-labeled 2-phenylbenzothiazoles as positron emission tomography imaging agents for amyloid plaques in Alzheimer's disease.
Katholieke Universiteit Leuven
Synthesis and evaluation of indolinyl- and indolylphenylacetylenes as PET imaging agents for beta-amyloid plaques.
University of Pennsylvania
Synthesis and evaluation of N-methyl and S-methyl 11C-labeled 6-methylthio-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridines as radioligands for imaging beta-amyloid plaques in Alzheimer's disease.
National Institute of Mental Health
Bis-styrylpyridine and bis-styrylbenzene derivatives as inhibitors for Abeta fibril formation.
Korea Institute of Science and Technology
Radioiodinated aza-diphenylacetylenes as potential SPECT imaging agents for beta-amyloid plaque detection.
University of Pennsylvania
Synthesis and structure-affinity relationships of new 4-(6-iodo-H-imidazo[1,2-a]pyridin-2-yl)-N-dimethylbenzeneamine derivatives as ligands for human beta-amyloid plaques.
National Institute of Mental Health
New diphenylacetylenes as probes for positron emission tomographic imaging of amyloid plaques.
University of Pennsylvania
Novel styrylpyridines as probes for SPECT imaging of amyloid plaques.
University of Pennsylvania
Rationally designed divalent caffeic amides inhibit amyloid-? fibrillization, induce fibril dissociation, and ameliorate cytotoxicity.
Academia Sinica
Resveratrol-maltol hybrids as multi-target-directed agents for Alzheimer's disease.
Zhejiang University
Synthesis and evaluation of 1,2,3,4-tetrahydro-1-acridone analogues as potential dual inhibitors for amyloid-beta and tau aggregation.
Sun Yat-Sen University
Success stories of natural product-based hybrid molecules for multi-factorial diseases.
Punjabi University
Novel 8-hydroxyquinoline derivatives targeting ?-amyloid aggregation, metal chelation and oxidative stress against Alzheimer's disease.
Pharmaceutical University
New phenylaniline derivatives as modulators of amyloid protein precursor metabolism.
University of Lille
Regioselective synthesis of 7-O-esters of the flavonolignan silibinin and SARs lead to compounds with overadditive neuroprotective effects.
Julius-Maximilians-Universit£T W£Rzburg
Discovery of novel scaffolds for ?-secretase modulators without an arylimidazole moiety.
Astellas Pharma
Novel sarsasapogenin-triazolyl hybrids as potential anti-Alzheimer's agents: Design, synthesis and biological evaluation.
Shenyang Pharmaceutical University
Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.
Jamia Millia Islamia (Central University)
Discovery of a Tetrahydrobenzisoxazole Series of ?-Secretase Modulators.
Merck Research Laboratories
Hydroxy-substituted trans-cinnamoyl derivatives as multifunctional tools in the context of Alzheimer's disease.
Alma Mater Studiorum-University of Bologna
Structure-activity relations of rosmarinic acid derivatives for the amyloid ? aggregation inhibition and antioxidant properties.
Muroran Institute of Technology
Isoxazole-tethered diarylheptanoid analogs: Discovery of a new drug-like PAR2 antagonist.
Advinus Therapeutics
Discovery of tetrahydroindazoles as a novel class of potent and in vivo efficacious gamma secretase modulators.
Boehringer Ingelheim Pharma
Structure-activity relationship of clovamide and its related compounds for the inhibition of amyloid? aggregation.
University of Tsukuba
Site-specific inhibitory mechanism for amyloid ß42 aggregation by catechol-type flavonoids targeting the Lys residues.
Kyoto University